LOGIN
Botulinum Toxin Type A for Chronic Low Back Pain
February 2025
Botulinum Toxin Type A for Chronic Low Back Pain
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Botulinum toxin type A for treating chronic low back pain: A double blinded randomized control study.
World J Methodol . 2024 Sep 20;14(3):93854.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Forty-four patients with chronic low back pain were randomized to receive either Botulinum toxin type A (BoNT-A; n=22) or a placebo (n=22). The primary outcome was the reduction in pain, measured by the Visual Analog Scale (VAS). Secondary outcomes included disability assessed by the Oswestry Disability Index (ODI) and the safety of the intervention. Outcomes were evaluated at baseline and after 8...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.